M.J. Garle

644 total citations
24 papers, 539 citations indexed

About

M.J. Garle is a scholar working on Pharmacology, Molecular Biology and Physiology. According to data from OpenAlex, M.J. Garle has authored 24 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 5 papers in Molecular Biology and 5 papers in Physiology. Recurrent topics in M.J. Garle's work include Pharmacogenetics and Drug Metabolism (6 papers), Animal testing and alternatives (4 papers) and Nitric Oxide and Endothelin Effects (3 papers). M.J. Garle is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), Animal testing and alternatives (4 papers) and Nitric Oxide and Endothelin Effects (3 papers). M.J. Garle collaborates with scholars based in United Kingdom, Italy and United States. M.J. Garle's co-authors include Jeffrey R. Fry, S P H Alexander, Julia H. Fentem, Suzanne P. Murphy, Andrew J. Bennett, Yu Sun, Claire L. Gibson, Dave Kendal, Katherine N. Hewitt and Alison H. Hammond and has published in prestigious journals such as British Journal of Pharmacology, British Journal of Anaesthesia and Toxicology and Applied Pharmacology.

In The Last Decade

M.J. Garle

24 papers receiving 523 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.J. Garle United Kingdom 12 172 124 81 79 74 24 539
Michael J. Garle United Kingdom 12 361 2.1× 159 1.3× 173 2.1× 124 1.6× 43 0.6× 27 736
Toshiaki Amamoto Japan 14 135 0.8× 162 1.3× 40 0.5× 47 0.6× 28 0.4× 21 578
R. Ceserani Italy 14 141 0.8× 102 0.8× 132 1.6× 47 0.6× 49 0.7× 52 530
George Lukas Switzerland 7 71 0.4× 97 0.8× 41 0.5× 50 0.6× 32 0.4× 12 445
Hiroyuki Akai Japan 11 114 0.7× 273 2.2× 40 0.5× 72 0.9× 28 0.4× 14 629
Nuria Olea‐Herrero Spain 10 246 1.4× 144 1.2× 50 0.6× 62 0.8× 11 0.1× 13 616
Myoung‐Yun Pyo South Korea 14 68 0.4× 128 1.0× 40 0.5× 22 0.3× 16 0.2× 22 558
S. Sırrı Bilge Türkiye 11 95 0.6× 143 1.2× 53 0.7× 86 1.1× 14 0.2× 28 485
D. Sylvester United States 13 31 0.2× 173 1.4× 76 0.9× 79 1.0× 62 0.8× 29 605
Elke Röhrdanz Germany 14 46 0.3× 274 2.2× 82 1.0× 36 0.5× 28 0.4× 16 705

Countries citing papers authored by M.J. Garle

Since Specialization
Citations

This map shows the geographic impact of M.J. Garle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.J. Garle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.J. Garle more than expected).

Fields of papers citing papers by M.J. Garle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.J. Garle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.J. Garle. The network helps show where M.J. Garle may publish in the future.

Co-authorship network of co-authors of M.J. Garle

This figure shows the co-authorship network connecting the top 25 collaborators of M.J. Garle. A scholar is included among the top collaborators of M.J. Garle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.J. Garle. M.J. Garle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Roberts, Richard, et al.. (2017). A critical role for cystathionine-β-synthase in hydrogen sulfide-mediated hypoxic relaxation of the coronary artery. Vascular Pharmacology. 93-95. 20–32. 16 indexed citations
3.
4.
Garle, M.J., et al.. (2014). A role for the sodium pump in H2O2-induced vasorelaxation in porcine isolated coronary arteries. Pharmacological Research. 90. 25–35. 10 indexed citations
5.
Wei, Jianlu, et al.. (2008). Examination of the effect of procalcitonin on human leucocytes and the porcine isolated coronary artery. British Journal of Anaesthesia. 100(5). 612–621. 13 indexed citations
6.
Sun, Yu, S P H Alexander, M.J. Garle, et al.. (2007). Cannabinoid activation of PPARα; a novel neuroprotective mechanism. British Journal of Pharmacology. 152(5). 734–743. 192 indexed citations
7.
Hammond, Alison H., et al.. (2002). Modulation of hepatocyte thiol content by medium composition: implications for toxicity studies. Toxicology in Vitro. 16(3). 259–265. 9 indexed citations
8.
Garle, M.J., et al.. (1999). Fluorescein Cadaverine Incorporation as a Novel Technique for the Characterization of Terminal Differentiation in Keratinocytes. Toxicology in Vitro. 13(4-5). 773–778. 13 indexed citations
9.
Bull, Sarah, et al.. (1999). Imipramine for Cytochrome P450 Activity Determination: a Multiple-species Metabolic Probe. Toxicology in Vitro. 13(4-5). 537–541. 6 indexed citations
10.
Garle, M.J., et al.. (1998). Human keratinocyte cultures in an in vitro approach for the assessment of surfactant-induced irritation. Toxicology in Vitro. 12(2). 163–173. 30 indexed citations
11.
Garle, M.J., et al.. (1996). Nitrite synthesis in a murine macrophage cell line stimulated by products released from irritant-treated normal human keratinocytes. Toxicology in Vitro. 10(3). 265–271. 6 indexed citations
12.
Clothier, Richard H., et al.. (1994). Development of a fixed-dose approach for the fluorescein leakage test. Toxicology in Vitro. 8(4). 883–884. 9 indexed citations
13.
Cookson, Mark, et al.. (1994). Phase 1 of an in vitro neurotoxicological pre-validation trial. Toxicology in Vitro. 8(4). 799–802. 7 indexed citations
14.
Garle, M.J., Julia H. Fentem, & Jeffrey R. Fry. (1994). In vitro cytotoxicity tests for the prediction of acute toxicity in vivo. Toxicology in Vitro. 8(6). 1303–1312. 63 indexed citations
15.
Fentem, Julia H., Alison H. Hammond, M.J. Garle, & Jeffrey R. Fry. (1992). Toxicity of coumarin and various methyl derivatives in cultures of rat hepatocytes and V79 cells. Toxicology in Vitro. 6(1). 21–25. 32 indexed citations
16.
Fry, Jeffrey R., M.J. Garle, & Kanhaiya Lal. (1992). Differentiation of cytochrome P-450 inducers on the basis of 7-alkoxycoumarinO-dealkylase activities. Xenobiotica. 22(2). 211–215. 17 indexed citations
17.
Fry, Jeffrey R., M.J. Garle, Alison H. Hammond, & Alan K. Hatfield. (1990). Correlation of acute lethal potency with in vitro cytotoxicity. Toxicology in Vitro. 4(3). 175–178. 27 indexed citations
18.
Garle, M.J. & Jeffrey R. Fry. (1990). Reactive metabolite formation catalysed by cytochrome P-450j. Toxicology in Vitro. 4(4-5). 493–496. 4 indexed citations
19.
Fry, Jeffrey R., M.J. Garle, & Alison H. Hammond. (1990). Competing pathways in metabolism-mediated cytotoxicity in vitro. Toxicology in Vitro. 4(4-5). 467–473. 6 indexed citations
20.
Garle, M.J., Jalaluddin A. Khan, & Jeffrey R. Fry. (1988). Depletion of glutathione by the hepatotoxins paracetamol and bromobenzene, and their non-hepatotoxic analogues, in a fortified liver microsomal system. Toxicology in Vitro. 2(4). 247–252. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026